Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sparano

Showing results (351-360 of 560) with videos related to

Pageof 56
Sort By:
The Journal of Chemical Physics|January 23, 2017
Two-structure thermodynamics for the TIP4P/2005 model of water covering supercooled and deeply stretched regionsJohn W Biddle, Rakesh S Singh, Evan M Sparano, et al.
Journal of Public Health Research|August 14, 2025
Clinician's knowledge and awareness of patient-reported outcomes in immune thrombocytopenia: Results of a national survey (ITP NET, GIMEMA Working Group Anemia and Thrombocytopenia)Esther Natalie Oliva, Fabio Efficace, Maria Rosa Valvano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2012
Akt inhibitors MK-2206 and nelfinavir overcome mTOR inhibitor resistance in diffuse large B-cell lymphomaAdam M Petrich, Violetta Leshchenko, Pei-Yu Kuo, et al.
JCO Precision Oncology|January 16, 2018
Impact of Genetic Ancestry on Outcomes in ECOG-ACRIN-E5103Bryan P Schneider, Fei Shen, Guanglong Jiang, et al.
Leukemia Research|November 26, 2009
Response to recombinant erythropoietin alpha, without the adjunct of granulocyte-colony stimulating factor, is associated with a longer survival in patients with transfusion-dependent myelodysplastic syndromesPellegrino Musto, Oreste Villani, Maria Carmen Martorelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Multiinstitutional phase II trial of intensive combination chemoimmunotherapy for metastatic melanomaM B Atkins, K R O'Boyle, J A Sosman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 12, 2020
Differences in Patient-Reported Outcomes That Are Most Frequently Detected in Randomized Controlled Trials in Patients With Solid Tumors: A Pooled Analysis of 229 TrialsJohannes M Giesinger, Jane Blazeby, Neil K Aaronson, et al.
Blood|November 20, 2004
Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trialsMichele Spina, Ulrich Jaeger, Joseph A Sparano, et al.
Virchows Archiv : an International Journal of Pathology|May 13, 2025
Development of an automated artificial intelligence-based tool for reticulin fibrosis assessment in bone marrow biopsiesGiuseppe D'Abbronzo, Antonio D'Antonio, Annarosaria De Chiara, et al.
Journal of Neurosurgical Sciences|March 5, 2016
Deep brain stimulation for intractabile epilepsyRoberta Morace, Giancarlo DI Gennaro, Pierpaolo Quarato, et al.
Pageof 56

Showing results (351-360 of 560) with videos related to

Sort By:
Pageof 56
The Journal of Chemical Physics|January 23, 2017
Two-structure thermodynamics for the TIP4P/2005 model of water covering supercooled and deeply stretched regionsJohn W Biddle, Rakesh S Singh, Evan M Sparano, et al.
Journal of Public Health Research|August 14, 2025
Clinician's knowledge and awareness of patient-reported outcomes in immune thrombocytopenia: Results of a national survey (ITP NET, GIMEMA Working Group Anemia and Thrombocytopenia)Esther Natalie Oliva, Fabio Efficace, Maria Rosa Valvano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2012
Akt inhibitors MK-2206 and nelfinavir overcome mTOR inhibitor resistance in diffuse large B-cell lymphomaAdam M Petrich, Violetta Leshchenko, Pei-Yu Kuo, et al.
JCO Precision Oncology|January 16, 2018
Impact of Genetic Ancestry on Outcomes in ECOG-ACRIN-E5103Bryan P Schneider, Fei Shen, Guanglong Jiang, et al.
Leukemia Research|November 26, 2009
Response to recombinant erythropoietin alpha, without the adjunct of granulocyte-colony stimulating factor, is associated with a longer survival in patients with transfusion-dependent myelodysplastic syndromesPellegrino Musto, Oreste Villani, Maria Carmen Martorelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1994
Multiinstitutional phase II trial of intensive combination chemoimmunotherapy for metastatic melanomaM B Atkins, K R O'Boyle, J A Sosman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 12, 2020
Differences in Patient-Reported Outcomes That Are Most Frequently Detected in Randomized Controlled Trials in Patients With Solid Tumors: A Pooled Analysis of 229 TrialsJohannes M Giesinger, Jane Blazeby, Neil K Aaronson, et al.
Blood|November 20, 2004
Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trialsMichele Spina, Ulrich Jaeger, Joseph A Sparano, et al.
Virchows Archiv : an International Journal of Pathology|May 13, 2025
Development of an automated artificial intelligence-based tool for reticulin fibrosis assessment in bone marrow biopsiesGiuseppe D'Abbronzo, Antonio D'Antonio, Annarosaria De Chiara, et al.
Journal of Neurosurgical Sciences|March 5, 2016
Deep brain stimulation for intractabile epilepsyRoberta Morace, Giancarlo DI Gennaro, Pierpaolo Quarato, et al.
Pageof 56